Literature DB >> 15476678

Shift in purine/pyrimidine base recognition upon exchanging extracellular domains in P2Y 1/6 chimeric receptors.

Carsten Hoffmann1, Kelly Soltysiak, Patrick L West, Kenneth A Jacobson.   

Abstract

P2Y receptors are G protein-coupled receptors stimulated by extracellular nucleotides. Both the P2Y(1) and the P2Y(6) receptors are preferentially activated by nucleoside 5'-diphosphates, but favor different base moieties. In the case of the P2Y(1) receptor the preferred base is adenine, while the P2Y(6) receptor is activated by uracil nucleotides. To identify potential amino acid domains that interact with the base moiety, we used a chimeric receptor approach, employing the human P2Y(1) receptor as core structure to investigate the role in receptor activation of extracellular loops (ELs) and transmembrane domains (TMs) of the rat P2Y(6) receptor. The chimeric receptors were expressed in COS-7 cells and measured for stimulation of phospholipase C (PLC) induced by the potent P2Y(1) receptor agonist 2-MeSADP or the potent P2Y(6) receptor agonist UDP. Replacement of the N-terminus or EL2 resulted in low ( approximately 50 microM) potency of the agonist 2-MeSADP, thus confirming the importance of EL2 in ligand recognition. Upon replacement of several regions, the potency of the P2Y(1) agonist 2-MeSADP was either 1-2 microM (N-terminus and EL1, or EL1 and EL3) or 72 microM (N-terminus and EL3). Concurrent replacement of three regions (N-terminus, EL1, and EL3) completely precluded activation by 2-MeSADP. Our study identified domains of the P2Y(6) receptor that contribute to receptor activation by UDP and hence seem to be involved in uracil recognition. Upon replacement with extracellular domains of the P2Y(6) receptor sequence we observed a trend toward gain of receptor-induced PLC activation by UDP, for example, in the chimera containing replacements of both the N-terminus and EL1. Exchange of three receptor domains led to a construct with an EC(50) value for UDP of 19 microM and a maximal inositol phosphate accumulation similar to the native P2Y(6) receptor. Within receptor constructs of combined domain exchanges the additional substitution of Tyr(110) by the corresponding Asn from the P2Y(6) receptor showed a significant increase for activation by UDP, but only when combined with the N-terminal domain and TM1. The residue Tyr(110) was identified to play an important role in the recognition of the nucleobase in the P2Y(1) and P2Y(6) receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15476678      PMCID: PMC4371599          DOI: 10.1016/j.bcp.2004.07.014

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  38 in total

1.  Electrostatic and aromatic microdomains within the binding-site crevice of the D2 receptor: contributions of the second membrane-spanning segment.

Authors:  J A Javitch; J A Ballesteros; J Chen; V Chiappa; M M Simpson
Journal:  Biochemistry       Date:  1999-06-22       Impact factor: 3.162

2.  Discovery of an ectopic activation site on the M(1) muscarinic receptor.

Authors:  Tracy A Spalding; Carol Trotter; Niels Skjaerbaek; Terri L Messier; Erika A Currier; Ethan S Burstein; Donghui Li; Uli Hacksell; Mark R Brann
Journal:  Mol Pharmacol       Date:  2002-06       Impact factor: 4.436

3.  Agonist action of adenosine triphosphates at the human P2Y1 receptor.

Authors:  R K Palmer; J L Boyer; J B Schachter; R A Nicholas; T K Harden
Journal:  Mol Pharmacol       Date:  1998-12       Impact factor: 4.436

4.  Lack of nucleotide-promoted second messenger signaling responses in 1321N1 cells expressing the proposed P2Y receptor, p2y7.

Authors:  C L Herold; Q Li; J B Schachter; T K Harden; R A Nicholas
Journal:  Biochem Biophys Res Commun       Date:  1997-06-27       Impact factor: 3.575

5.  Towards a revised nomenclature for P1 and P2 receptors.

Authors:  B B Fredholm; M P Abbracchio; G Burnstock; G R Dubyak; T K Harden; K A Jacobson; U Schwabe; M Williams
Journal:  Trends Pharmacol Sci       Date:  1997-03       Impact factor: 14.819

6.  Use of eukaryotic expression technology in the functional analysis of cloned genes.

Authors:  B R Cullen
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

7.  Phosphoinositide hydrolysis by guanosine 5'-[gamma-thio]triphosphate-activated phospholipase C of turkey erythrocyte membranes.

Authors:  T K Harden; P T Hawkins; L Stephens; J L Boyer; C P Downes
Journal:  Biochem J       Date:  1988-06-01       Impact factor: 3.857

8.  Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets.

Authors:  J Jin; J L Daniel; S P Kunapuli
Journal:  J Biol Chem       Date:  1998-01-23       Impact factor: 5.157

9.  P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors.

Authors:  M S Fagura; I A Dainty; G D McKay; I P Kirk; R G Humphries; M J Robertson; I G Dougall; P Leff
Journal:  Br J Pharmacol       Date:  1998-05       Impact factor: 8.739

10.  Double tagging recombinant A1- and A2A-adenosine receptors with hexahistidine and the FLAG epitope. Development of an efficient generic protein purification procedure.

Authors:  A S Robeva; R Woodard; D R Luthin; H E Taylor; J Linden
Journal:  Biochem Pharmacol       Date:  1996-02-23       Impact factor: 5.858

View more
  5 in total

Review 1.  Nucleotides Acting at P2Y Receptors: Connecting Structure and Function.

Authors:  Kenneth A Jacobson; Silvia Paoletta; Vsevolod Katritch; Beili Wu; Zhan-Guo Gao; Qiang Zhao; Raymond C Stevens; Evgeny Kiselev
Journal:  Mol Pharmacol       Date:  2015-04-02       Impact factor: 4.436

Review 2.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

3.  Agonist-selective, receptor-specific interaction of human P2Y receptors with beta-arrestin-1 and -2.

Authors:  Carsten Hoffmann; Nicole Ziegler; Susanne Reiner; Cornelius Krasel; Martin J Lohse
Journal:  J Biol Chem       Date:  2008-08-14       Impact factor: 5.157

Review 4.  Agonists and antagonists for P2 receptors.

Authors:  Kenneth A Jacobson; Stefano Costanzi; Bhalchandra V Joshi; Pedro Besada; Dae Hong Shin; Hyojin Ko; Andrei A Ivanov; Liaman Mamedova
Journal:  Novartis Found Symp       Date:  2006

5.  Demystifying P2Y1 Receptor Ligand Recognition through Docking and Molecular Dynamics Analyses.

Authors:  Antonella Ciancetta; Robert D O'Connor; Silvia Paoletta; Kenneth A Jacobson
Journal:  J Chem Inf Model       Date:  2017-11-28       Impact factor: 4.956

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.